If NIH research fellow Kizzmekia Corbett's team is successful — meaning phase one, two and three clinical trials prove the team's work has produced a safe, working vaccine — something to prevent infection with the coronavirus could be ready for use in doctors' offices by early to mid-2021. COVID-19 could become a preventable disease. "There was, and is, already a fair amount of pressure," she said. "A lot of people are banking on us or feel that we have a product that could, at least, be part of the answer this world needs. And, well, whew, just saying that out loud is not easy." | 
No comments:
Post a Comment